AUM$142.2M
Expense Ratio0.75%
NAV$35.65
Holdings57
InceptionAug 14, 2023
Price Chart
Key Statistics
Previous Close
$36.33Day Range
$35.87$36.78
52-Week Range
$20.98$37.78
Avg Volume
30.3KDividend Yield
0.05%Expense Ratio
0.75%AUM
$142.2MShares Outstanding
3.2MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 76.34% |
| Switzerland | 8.50% |
| United Kingdom | 4.95% |
| Denmark | 2.95% |
| Other | 1.89% |
| China | 1.75% |
| Canada | 1.55% |
| Japan | 1.16% |
| Hong Kong | 0.58% |
| Cayman Islands | 0.34% |
Fund Information
- Issuer
- Tema
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Aug 14, 2023
- Exchange
- NASDAQ
- Description
- The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.
Similar ETFs
The Tema Oncology ETF (CANC) is an exchange-traded fund issued by Tema that launched on Aug 14, 2023. It currently manages $142.2M in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 57 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 40.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 5.95% | 99,022 | $9.9M |
| 2 | NOVN.SW | NOVARTIS AG | 4.36% | 46,549 | $7.2M |
| 3 | AZN.L | ASTRAZENECA PLC | 4.36% | 37,229 | $7.2M |
| 4 | LLY | ELI LILLY & CO | 4.17% | 6,910 | $6.9M |
| 5 | RHHBY | ROCHE HOLDING AG | 4.14% | 128,593 | $6.9M |
| 6 | BBIO | BRIDGEBIO PHARMA INC | 3.83% | 89,091 | $6.4M |
| 7 | BMY | BRISTOL-MYERS SQUIBB CO | 3.55% | 98,176 | $5.9M |
| 8 | ACLX | ARCELLX INC | 3.52% | 50,968 | $5.8M |
| 9 | MRK | MERCK & CO INC | 3.37% | 48,042 | $5.6M |
| 10 | IMNM | IMMUNOME INC | 3.30% | 255,970 | $5.5M |
| 11 | NUVL | NUVALENT INC | 3.13% | 51,907 | $5.2M |
| 12 | COGT | COGENT BIOSCIENCES INC | 3.10% | 142,695 | $5.1M |
| 13 | CELC | CELCUITY INC | 3.10% | 44,438 | $5.1M |
| 14 | GMAB | GENMAB A/S | 2.95% | 178,924 | $4.9M |
| 15 | JNJ | JOHNSON & JOHNSON | 2.51% | 17,131 | $4.2M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -0.94% | — | ||
| 1W | -1.37% | — | ||
| 1M | -0.56% | — | ||
| 3M | +3.96% | — | ||
| 6M | +33.59% | — | ||
| YTD | +5.04% | — | ||
| 1Y | +44.74% | — | ||
| 3Y | +44.89% | — | ||
| 5Y | +44.89% | — |
Moving Averages
20-Day MA
$37.06
Below 20-Day MA50-Day MA
$36.42
Below 50-Day MA200-Day MA
$30.31
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.78
Current Price
$35.99
52-Week Low
$20.98
$20.98$37.78
Current Yield
0.05%
Annual Dividend
$0.8970
Frequency
1x/year
Last Ex-Date
Dec 10, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 10, 2025 | $0.0196 | Dec 11, 2025 |
| Dec 11, 2024 | $0.7283 | Dec 12, 2024 |
| Dec 13, 2023 | $0.1491 | Dec 15, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | CANC | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.75% | 0.60% | 0.83% |
| AUM | $142.2M | $1.24B | $1.51B |
| Dividend Yield | 0.05% | 2.75% | 2.14% |
| Avg Volume | 30.3K | 800.9K | 1.3M |
| Holdings | 57 | 171 | 66 |
| Performance | |||
| 1-Month Return | -0.71% | -4.57% | -3.93% |
| 6-Month Return | +34.88% | +4.90% | +15.68% |
| YTD Return | +4.64% | -1.70% | -2.78% |
| 1-Year Return | +46.85% | +15.18% | +25.33% |
Compare with Another ETF
Search for an ETF to compare with CANC: